Immediate Impact

56 standout
Sub-graph 1 of 24

Citing Papers

Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss Among Adults Without Diabetes
2025 Standout
Type 2 Diabetes Mellitus: New Pathogenetic Mechanisms, Treatment and the Most Important Complications
2025 Standout
2 intermediate papers

Works of Kelley Newlin being referenced

Incretin‐based therapies: Therapeutic rationale and pharmacological promise for type 2 diabetes
2009

Author Peers

Author Last Decade Papers Cites
Kelley Newlin 231 189 113 14 452
Siva Subramanian 82 128 57 12 444
Najmeh Jafari 189 119 25 22 410
Wilbur H. Watson 83 131 131 18 497
Kelly Gonzales 80 158 52 31 479
Laura Wilder 231 238 22 11 395
Charmaine Ruddock 74 228 39 16 377
Mara Laderman 63 218 47 13 464
Nelma B. Crawford Shearer 89 271 54 19 510
Chii‐Jun Chiou 58 129 46 20 423
Lars Møller 53 184 47 9 469

All Works

Loading papers...

Rankless by CCL
2026